MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202527111173 A) filed by Zydus Lifesciences Limited on November 14, 2025, for Treatment For Amyotrophic Lateral Sclerosis (als).
Inventors include Agarwal, Sameer; Parmar, Deven V.; Jain, Mukul; Chatterjee, Abhijit Number; Philip, Binu; Patel, Harilal; Viswanathan, Kasinath; and Sharma, Rajiv.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: Present invention relates to the development of therapeutic compound for the treatment of Amyotrophic lateral sclerosis (ALS). Specifically, the present invention provides a NLRP3 inhibitors or its pharmaceutically acceptable salt or suitable composition useful in the treatment of Amyotrophic lateral sclerosis (ALS) and other related disorders including progressive bulbar palsy, primary lateral sclerosis, progressive muscular atrophy, spinal muscular atrophy, Kennedy's disease, and post-polio syndrome. Formula (I)
Disclaimer: Curated by HT Syndication.
